- Report
- June 2026
- 561 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 301 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- June 2026
- 202 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- August 2025
- 150 Pages
Global
From €3578EUR$3,950USD£3,087GBP
- Report
- June 2026
- 277 Pages
Global
From €5299EUR$5,850USD£4,572GBP
- Report
- November 2025
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- January 2026
- 148 Pages
Global
From €3578EUR$3,950USD£3,087GBP
- Report
- January 2026
- 160 Pages
Global
From €3578EUR$3,950USD£3,087GBP
- Report
- October 2025
- 160 Pages
Global
From €3578EUR$3,950USD£3,087GBP
- Report
- August 2025
- 150 Pages
Global
From €3578EUR$3,950USD£3,087GBP
- Report
- August 2025
- 150 Pages
Global
From €3578EUR$3,950USD£3,087GBP
- Report
- January 2026
Global
From €6793EUR$7,500USD£5,861GBP
- Report
- June 2025
- 150 Pages
Global
From €4393EUR$4,850USD£3,790GBP
- Report
- March 2026
- 200 Pages
United States
From €5389EUR$5,950USD£4,650GBP
- Report
- June 2026
Europe
From €3614EUR$3,990USD£3,118GBP
- Report
- September 2025
- 28 Pages
United States
From €995EUR$1,177USD£888GBP
- Report
- September 2025
- 28 Pages
United States
From €995EUR$1,177USD£888GBP
- Report
- May 2021
- 177 Pages
United States
€1354EUR$1,495USD£1,168GBP
- Report
- September 2023
- 135 Pages
Global
From €4076EUR$4,500USD£3,517GBP
- Report
- May 2023
- 169 Pages
Global
From €2129EUR$2,350USD£1,836GBP

The AIDS market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs to treat HIV infection, as well as vaccines and other therapies to prevent the spread of the virus. Additionally, research is being conducted to better understand the mechanisms of HIV infection and the development of new treatments.
The market is highly competitive, with many companies vying for a share of the market. Companies such as Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare are all major players in the AIDS market. Other companies such as AbbVie, Janssen, and Pfizer are also involved in the development of treatments and therapies for HIV/AIDS. Show Less Read more